The elevated CSF and serum OPN levels were shown in both relapsing–remitting MS (RRSM) and secondary progressive MS (SPMS) patients19, moreover, higher OPN levels in CSF were measured in patients with active disease, as compared to patients with stable disease17. Here, SPP1 is linked to secondary progressive multiple sclerosis.